Seelos Therapeutics to Participate in Upcoming Investor Conference in November
2019年10月18日 - 10:00PM
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage
biopharmaceutical company, announced today that it will participate
in the Jefferies 2019 London Healthcare Conference. The company
will host One on One meetings in London, England on Wednesday,
November 20th and Thursday, November 21st.
About Seelos Therapeutics:
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical
company focused on the development and advancement of novel
therapeutics to address unmet medical needs for the benefit of
patients with central nervous system (CNS) disorders and other rare
disorders. The Company's robust portfolio includes several
late-stage clinical assets targeting psychiatric and movement
disorders, including orphan diseases. Seelos is based in New York,
New York.
For more information, please visit our website:
http://seelostherapeutics.com, the content of which is not
incorporated herein by reference.
Contact Information:Anthony MarcianoHead of Corporate
CommunicationsSeelos Therapeutics, Inc. (Nasdaq: SEEL)300 Park
Ave., 12th FlNew York, NY 10022(646)
293-2136anthony.marciano@seelostx.comwww.seelostherapeutics.comhttps://twitter.com/seelostx
https://www.linkedin.com/company/seelos
Seelos Therapeutics (NASDAQ:SEEL)
過去 株価チャート
から 9 2024 まで 10 2024
Seelos Therapeutics (NASDAQ:SEEL)
過去 株価チャート
から 10 2023 まで 10 2024